GLP-1, SGLT2 medications may lower stroke survivor’s risk of future heart attack, stroke
American Heart News - Stroke News
NOVEMBER 11, 2024
Research Highlights: In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 inhibitor medication had a lower risk of a subsequent stroke, heart attack or death compared to peers who were.
Let's personalize your content